Cargando…
Clinical characteristics of epileptic seizures in a case of dihydropteridine reductase deficiency
We assessed the clinical characteristics and efficacy of neurotransmitters and levetiracetam in a patient with hyperphenylalaninemia due to dihydropteridine reductase (DHPR) deficiency who developed epileptic seizures. A boy with DHPR deficiency, who had been successfully treated with tetrahydrobiop...
Autores principales: | Furujo, Mahoko, Kinoshita, Masako, Ichiba, Yozo, Romstad, Anne, Shintaku, Haruo, Kubo, Toshihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308063/ https://www.ncbi.nlm.nih.gov/pubmed/25667865 http://dx.doi.org/10.1016/j.ebcr.2014.01.007 |
Ejemplares similares
-
Parkinsonism in Association with Dihydropteridine Reductase Deficiency
por: Takahashi, Yoshiaki, et al.
Publicado: (2017) -
High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?
por: Vitturi, Nicola, et al.
Publicado: (2021) -
An Infant Case of Hyperprolactinemia Induced by a Functional Disorder of the
Hypothalamus
por: Kubo, Toshihide, et al.
Publicado: (2007) -
Genome sequencing identifies a homozygous inversion disrupting QDPR as a cause for dihydropteridine reductase deficiency
por: Lilleväli, Hardo, et al.
Publicado: (2020) -
Sapropterin dihydrochloride therapy in dihydropteridine reductase deficiency: Insight from the first case with molecular diagnosis in Brazil
por: Lourenço, Charles Marques, et al.
Publicado: (2021)